SEPRACOR INC /DE/
10-Q, EX-27, 2000-08-11
PHARMACEUTICAL PREPARATIONS
Previous: SEPRACOR INC /DE/, 10-Q, EX-3.1, 2000-08-11
Next: CITRIX SYSTEMS INC, 424B3, 2000-08-11



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                     272,178,000
<SECURITIES>                               457,666,000
<RECEIVABLES>                                4,370,000
<ALLOWANCES>                                   199,000
<INVENTORY>                                  6,592,000
<CURRENT-ASSETS>                           745,186,000
<PP&E>                                      34,276,000
<DEPRECIATION>                              14,383,000
<TOTAL-ASSETS>                             813,688,000
<CURRENT-LIABILITIES>                       77,219,000
<BONDS>                                    852,898,000
                                0
                                          0
<COMMON>                                     7,312,000
<OTHER-SE>                               (128,436,000)
<TOTAL-LIABILITY-AND-EQUITY>               813,688,000
<SALES>                                     23,501,000
<TOTAL-REVENUES>                            49,385,000
<CGS>                                        5,524,000
<TOTAL-COSTS>                                8,101,000
<OTHER-EXPENSES>                           116,093,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                          22,819,000
<INCOME-PRETAX>                           (85,345,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (85,345,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (85,345,000)
<EPS-BASIC>                                     (1.19)
<EPS-DILUTED>                                   (1.19)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission